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In the following work an attempt has been made to evaluate quantitatively 
the amounts of proteolytic enzyme and of trypsin inhibitor in patients' blood 
before, during, and after the onset of acute rheumatic fever.  The terminology 
suggested by Christensen and MacLeod (1945)  has been adopted.  Thus active 
serum proteinase is referred to as "plasmin;" the inactive precursor of plasmin 
is designated  "plasminogen;" the activator of plasminogen is called "strepto- 
kinase"  (formerly known as streptococcal fibrinolysin),  and  the specific anti- 
body against  the  activator is  termed  "antistreptokinase."  Christensen  and 
MacLeod (1945)  found that the proteolytic activity of plasmin is inhibited by 
both the crystalline pancreatic inhibitor of trypsin and by the trypsin inhibitor 
which is found in serum.  They also showed that both these inhibitors are less 
active against plasmin than against crystalline trypsin and that the different 
shapes  of inhibition  curves for the  two  enzymes suggest  that  there  are  also 
qualitative differences between the  inhibition  of trypsin and of plasmin.  In 
this  paper the  inhibitor of trypsin and  plasmin which  is present in  serum is 
referred to as "trypsin inhibitor" or "inhibitor."  The expression "total plas- 
min" is used to denote the proteolytic activity of serum in which the plasmino- 
gen  has  been  activated  by  an  excess  of  streptokinase.  The  total  plasmin 
level therefore comprises the sum of both spontaneously activated and strepto- 
kinase--activated plasminogen. 
* This work was commenced  while the author was a Visiting Investigator at the Hospital of 
The Rockefeller Institute for Medical Research supported by a grant  made to the British 
Medical Research Council  by the Wellcome  Trustees and assisted in part by a contract between 
The Rockefeller Institute  for Medical Research and the Commission  on Hemolytic Strepto- 
coccal Infections, Board for the Investigation and Control of Influenza and Other Epidemic 
Diseases in the Army, Preventive Medicine Service, Office of The Surgeon General, United 
States Army.  Continuation of the work was supported (in part) by a research grant from the 
United States Public Health Service at  The  Rheumatic Fever Research Institute,  North- 
western University, Chicago. 
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Materials and Methods 
The majority of the sera used in this investigation were obtained during March and April, 
1946, from scarlet fever patients at the Great Lakes Naval Training Center.  1  The patients were 
all young men of the same age group.  Blood samples were taken on admission  to the hospital 
and thereafter at weekly intervals until the patients returned to duty.  Specimens of serum 
were therefore available from scarlet fever patients who did not develop any complications and 
returned to duty after about 3 weeks in the hospital, from those who developed otitls media or 
other purulent complications and remained in the hospital for longer periods,  and finally, from 
those who developed rheumatic fever and received prolonged hospital treatment.  The sera 
were stored in the cold at about 4°C. without any added preservative in sterile tubes with rubber 
stoppem.  They supplied a series of samples in which the total potential proteolytic activity 
of the serum before the onset of rheumatic fever could be compared with the proteolytic activ- 
ity at the time of rheumatic onset and during subsequent weeks.  The sera from uncomplicated 
cases of scarlet fever and those from patients with purulent complications supplied controls for 
comparison with rheumatic fever sera. 
Substta~for Digestion Expcrimotts.--AzocoU 2  was used as the substrate in all the experiments 
described in this paper.  This substance was originally used by Oakley, Warrack,  and  van 
Heyningen  (1946) for titrating  collagenase  in filtrates from cultures of Clostridium wdchii. 
It is a  reddish  purple  insoluble powder prepared  by  coupling commerical "hide powder," 
which is a rich source of collagen, with an asodye.  When incubated with eollagenase  a deep 
red color is released into the suspending fluid by disintegration of the azocoll.  A similar re- 
lease of color occurs when azocoll is incubated with plasmin or with trypsin, chymotrypsin, 
pepsin, papain,  and  streptococcal proteinase.  Different preparations  of asocoll are not all 
digested to the same extent by the same amount of enzyme.  It is therefore important to use a 
single preparation for all observations if comparable results are desired. 
The following experiment was set up to determine the most suitable weight of substrate to 
use in digestion experiments.  A constant weight of 0.00025 mg. of crystalline trypsin was used 
to digest varying quantities of azocoll ranging from 20 to 30 rag. with a variation of 1 mg. per 
tube.  It was found that 20 to 25 rag. of azocoll gave a gradually increasing number of color 
units.  On the other hand 25 to 30 rag. of azocoll gave constant readings in color units.  It 
was therefore considered that 30 rag. of azocoU supplied an adequate excess of substrate and 
this quantity was used in all experiments. 
Streptokinase.--A  single preparation of streptokinase designated S. K. A. I.  t was used in all 
the experiments described in this paper.  This was prepared by a method similar to that de- 
scribed by Anderson, Kunkel, and McCarty (1948).  A group A strain, H105, was grown in 
neopeptone dialysate broth with the addition of sterile glucose solution and 5 N NaOH as re- 
quired.  The streptococci were removed by centrifugation.  The streptokinase in the super- 
1 The author is indebted to Lieutenant Commander John D. Seal,  Medical Corps, United 
States Navy, and the personnel of the United States Naval Medical Research Unit No. 4 for 
collection of sera and cultures and for supplying the clinical data on the patients.  Dr. Robert 
F. Watson and Dr. Rebecca C. Laneefield represented the Hospital of The Rockefeller Institute 
for Medical Research in setting up this cooperative project.  The author wishes to thank Dr. 
Homer F. Swift for organizing the joint program which made available the serum and cultures 
used in this investigation. 
2 The author is greatly indebted to Dr. Walther F. Goebel for the preparation of asoeoll in 
sufficient quantity to allow the same lot to be used in all the experiments required for this 
investigation. 
8 Streptokinase  (lot S.K.A.I.)  was kindly supplied by Dr. Maclyn McCarty in sufficient 
quantity to allow the same lot to be used in all the experiments required for this investigation. EDGAR  W.  TODD  297 
natant fluid was concentrated and partially purified by acid precipitation at pH 3.8 and by 
ammonium sulfate fractionation.  The final product was lyophilized and preserved in the dry 
state.  Experiments, which will be described in a later section of this paper, were carried out to 
determine the optimal quantity of this preparation of streptokinase (S. K. A. I.) for activation 
of plasminogen.  Thereafter, a standard quantity of S. K. A. I. was used in all experiments in 
order to obtain comparable results. 
Trypsin.--A single lot of crystalline trypsin  4 was used in all experiments. 
Trypsin Inhibitors.--Bovine  serum trypsin inhibitor was preserved in dried form.  5  The 
soya bean inhibitor of trypsin was preserved in crystalline form? 
Antistreptoklnase Determinations.--The  titrations of sera for antistreptokinase were carried 
out by the method described by Anderson, Kunkel, and McCarty (1948). 7 
General Method  for Estimation of Proteolytic  A ctivity.--The proteolytic activity of the enzyme 
systems under investigation is determined by measuring the amount of color released from a 
constant weight of azocoll after incubation for 30 minutes in a water bath at 37°C.  Imme- 
diately after incubation the tests are transferred to an ice water bath at about 4°C. for 15 min- 
utes to reduce proteolysis to a  minimum; they are then filtered through 7½ cm. filter papers  s 
to remove the residue of insoluble substrate.  The resulting colored filtrates are transferred to 
12  X  75 mm. cuvettes.  The per cent transmittance of light with a  wave length of 525 m# 
is then read on a  Coleman Junior spectrophotometer (Model 6A).  This is the optimal wave 
length for demonstrating differences in the color of azocoll digests.  The per cent transmittance 
of light is finally converted into arbitrary color units which are directly proportional to the 
proteolytic activity of the enzyme under test.  A straight line is obtained when the per cent 
transmittance of light for serial dilutions of azocoll digest filtrate is plotted on semilog paper 
against color units constructed by assigning a  value of  100 units to undiluted digest.  This 
curve is used to convert the per cent transmittance of light into color units in all subsequent 
experiments.  The relation of these color units to the proteolytic activity of different weights 
of crystalline trypsin can also be obtained by reference to a  curve constructed by plotting 
weights of trypsin against the color units released by the different quantities of trypsin from 
30 mg. of azocoll under the conditions described above. 
M/15 phosphate buffer at pH 7.8 mixed with an equal volume of normal saline is used to 
dilute  the  reagents and  to  suspend  the substrate.  All glassware and  rubber stoppers are 
autoclaved before use. 
The Titration of Plasmin  in Serum.--An attempt was made to titrate the total plasmin in 
serum after activation of plasminogen by streptokinase.  There are a number of difficulties in 
this procedure requiring special precautions.  The activity of the plasmin may be diminished 
by trypsin inhibitor in the serum, by inhibitor in the streptokinase, by antistreptokinase in the 
patient's serum (if insufficient streptokinase is added to the test), or by an absolute fall in the 
level of plasminogen and plasmin in the patient's serum.  The following method was adopted 
for titration of total plasmin.  Pyrex glass tubes labeled 13 X  100 ram. by the manufacturers 
are measured with calipers and those with internal diameters ranging from 10.9 to 11.0 ram. are 
selected and set up in a test tube rack.  To each tube 4.0 cc. of water is added and those which 
4 The crystalline trypsin was prepared by Dr. Maclyn McCarty. 
5 This inhibitor was prepared by Dr. E.  C. Loomis and supplied through the kindness of 
Dr. G. Ungar. 
6 The soya bean inhibitor of trypsin was prepared by Dr. M. Kunitz and supplied through 
the kindness of Dr. L. R. Christensen. 
7 The author is greatly indebted to Dr. H. C. Anderson and Dr. Maclyn McCarty who have 
generously allowed the use of their antistreptokinase determinations in this paper. 
s Schleicher and Schuell analytical filter paper S and S No. 597. 
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show the same water level are selected for use as "digestion tubes."  In carrying out tests for 
total plasmin the selected tubes are immersed in an ice water bath.  They then receive 2.6 cc. 
of buffer-saline at pH 7.8, 0.4 cc. of the undiluted serum to be tested, 1.0 cc. of a solution of 
streptokinase in suitable concentration, and 30  rag.  of azoco]l.  The tubes are closed  with 
rubber stoppers and shaken until the azocoll is thoroughly wetted and dispersed throughout the 
fluid.  They are then transferred to a water bath at 37°C. for 30 minutes during which time 
they are inverted several times at intervals of 5 minutes to promote contact between the enzyme 
and the insoluble substrate.  Mter 30 minutes at 37°C.  the tubes are transferred to an ice 
water bath for 15 minutes.  Each tube is then inverted several times to mix the contents and 
the suspension  is immediately filtered through paper.  The resulting colored filtrates supply the 
material for estimation of color units as already described.  A serum of known plasmin activity 
is included in each set of titrations. 
TABLE  I 
Titration of Trypsin Inhibitor in Serum 
No. of test 
or control 
Test 1 
tt  2 
"  3 
Control 1 
"  2 
"  3 
"  4 
Vol-  olu~ 
ume  of 
of  ~eru~ 
mffel  tilut~ 
~lim  ./,L~ 
2.2  0.8 
2.2  0.8 
2.2  0.8 
3.0  0.0 
3.0  0.0 
3.0  0.0 
4.0  0.0 
Volume 
of 
trypsin 
0.00025 
mg./cc. 
1.0 
1.0 
1.0 
1.0 
1.0 
1.0 
0.0 
15  min. 
in 37°C. 
water 
bath 
5  rain. 
in  ice 
water 
bath 
#tg. 
30 
30 
30 
30 
30 
30 
30 
30  rain. 
at 37°C. 
with in- 
version 
every  5 
rain. 
15  rain. 
in  ice 
water 
bath 
Filtered 
through 
paper 
The Titration of Trypsin Inhibitor in Serum.--A solution of I0 rag. of crystalline trypsin is 
made in 2.0 cc. of distilled water.  Volumes of 0.1 cc. of this solution are pipetted into small 
10 X  75 ram. tubes with 0.2 cc. pipettes2  The tubes are then closed by rubber stoppers with 
sleeve caps and stored at -28°C.  On the day of the test the contents of one of these tubes is 
allowed to thaw and 1.9 cc. of buffer-saline  is then added and mixed, making a solution of 0.25 
rag. of trypsin per cc.  A volume of 0.1 cc. of this solution is measured with a 0.2 cc. pipette 
into a volumetric flask and the final volume of the trypsin solution is made up with buffer-saline 
to 100 cc. containing 0.00025 rag. per cc.  These tests are then set up in pyrex digestion tubes, 
of equal diameter  by adding to each tube 2.2 cc. of buffer-saline, 0.8 cc. of serum diluted 1/5,000, 
and 1.0 cc. of trypsin solution containing 0.00025 rag. of crystalline trypsin.  They are mixed 
and incubated in a water bath at 37°C. for 15 minutes to allow time for combination of trypsin 
and inhibitor.  They are then transferred to a chilled water bath for 5 minutes; and 30 nag. of 
azocoll is added to each tube.  The tubes are then stoppered, shaken, incubated at 37°C. for 
30 minutes, with inversions every 5 minutes, immersed for 15 minutes in ice water, and filtered 
through paper as previously described.  The serum dilutions are made with 0.2 cc. pipettes as 
follows: 0.1 cc. undiluted serum -{- 4.9 cc. buffer-saline =  1/50; 0.1 cc. of 1/50 serum -{- 9.9 cc. 
of buffer-saline  =  1/5,000.  The tests are then set up as shown in Table I. 
In Table I  tests 1, 2, and 3 represent three different sera under test.  Controls 1, 2, and 3 
are three separate determinations of the proteolytic activity of 0.00025 nag. of trypsin alone 
s Kimble brand serological pipettes.  EXAX 0.2 ml. in 0.01 ml. EDGAR W.  TODD  299 
without any serum; these are included in every set of titrations and their average value is used 
to calculate the per cent inhibition of trypfic digestion by each serum under test.  Control 4, 
which is also included in each set of fitrafions, gives the amount of color which escapes from 
30 rag. azocoU into 4.0 cc. of buffer-saline at pH 7.8 in 30 minutes at 37°C.  This solution is 
used as the reference  (T per cent  =  100) when  reading the results of tests in the spectro- 
photometer.  It gives a fairly constant reading of about 80 per cent transmittance with this 
particular lot of azocoll when buffer-saline is used as the reference.  There is, however, con- 
siderable variation in this respect between different preparations of azocoI1. 
Additional control tubes containing diluted serum without any trypsin were included in the 
earlier titrations.  It will be demonstrated in a later section of this paper that these serum 
controls were unnecessary; they were therefore omitted in later titrations. 
EXPERIMENTAL RESULTS 
Determination  of Optimal Time of Incubation for Digestion Experiments 
The following experiment was carried out to determine the optimal time of 
incubation  to  avoid accumulation  of digestion products  which  might  inhibit 
proteolysis by plasmin. 
Five digestion tubes were set up each containing 2.6 cc. of buffer-saline, 0.4 cc. of human 
serum,  1.0 cc. of streptokinase, in suitable dilution,  and 30 rag. of azocoll.  The tubes were 
incubated at 37°C. in the usual way; determinations of the number of color units liberated from 
the azocoll were made every 15 minutes for 75 minutes.  The result of this experiment is shown 
in Fig. 1. 
It will be seen from Fig. 1 that a linear curve was obtained up to 30 minutes. 
A  standard incubation time of 30 minutes was  therefore adopted in all experi- 
ments. 
The Effect  of Trypsin Inhibitor in Serum on the Estimation  of Total Plasmin 
The  degree of inhibition of plasmin activity by serum  inhibitor is  largely 
dependent  on  the  time  allowed for  combination  of  enzyme  and  inhibitor at 
37 ° C. before the addition of substrate.  No combining time is therefore allowed 
in the method already described for the estimation of total plasmin; and the 
reagents  are  kept  cold  during  the  time  required  for  pipetting  and  mixing. 
The following experiments were carried out  to investigate the results of these 
attempts to minimize the action of serum inhibitor on plasmin activity. 
The results of titrating separately the total plasmin and the trypsin inhibitor 
in samples of serum  taken  at  intervals from  the  same patient  indicate  that 
under the conditions of the tests there 'is not a  reciprocal relationship between 
the  readings obtained for  total plasmin and  for  trypsin inhibitor.  In  other 
words, an increase of inhibitor is not necessarily accompanied by a  decrease of 
total plasmin.  Conversely a  fall in inhibitor level frequently coincides with a 
similar fall of total plasmin.  This is shown in Fig. 2 which gives the results of 
total plasmin and of inhibitor titrations in sera taken at intervals from a patient 
with  uncomplicated  scarlet fever. 300  TOTAL PLASMIN  AND  TRYPSIN  INHIBITOR.  I 
It  will be  seen  that  the  curves  for  total  plasmin  and  for  trypsin  inhibitor 
are of similar shape in Fig.  2. 
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FIG.  1.  Determination of optimal time of incubation for digestion experiments.  Abscissae 
give time of incubation in minutes.  Ordinates give color units liberated from 30 rag. of azocoll. 
Fro.  2.  Results of titrating the total plasmin and the trypsin inhibitor in sera taken at 
intervals from a  patient with uncomplicated scarlet fever.  The ordinates give the plasmin 
levels of the sera expressed as color units recorded thus e--O  and the percentage inhibition of 
trypsin by the sera recorded thus O--O.  The curves have similar shapes. 
These results seemed to indicate that the methods employed were satisfactory 
for the separate determinations of totalplasmin  and of trypsin inhibitor,  The 
following experiment was carried out to obtain more direct evidence as to the 
effect of trypsin  inhibitor on the estimation of total plasmin. 
A solution of dried bovine trypsin inhibitor in buffer-saline  was made of sufficient concen- 
tration to cause about 50 per cent inhibition of 0.0025  rag. of crystalline trypsin.  Five serial 
twofold dilutions of this solution were made in buffer-saline and  1.0 ce. of each dilution was 
pipetted into a digestion tube.  These tubes then received 2.0 ce. of buffer-saline  and ii0 cc. 
of a solution containing 0.00025 rag. of crystalline trypsin per cc.  The tubes were incubated for EDGAR W,  TODD  301 
15 minutes to allow combination of trypsin and inhibitor.  The residual active trypsin in each 
tube was then determined as previously described.  Similarly 1.0 cc. of each dilution of in- 
hibitor was added to a second series of digestion tubes containing 1.6 cc. of buffer-saline, 0.4 cc. 
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FIG.  3.  The effect of bovine trypsin inhibitor on the titration of total plasmin in normal 
human serum when the precautions described under Methods are used.  Ordinates give the 
percentage inhibition of plasmin recorded thus o--e  and the percentage inhibition of trypsin 
recorded thus 0--o.  Abscissae give dilutions of inhibitor and control titrations without any 
bovine inhibitor.  Under these conditions the inhibitor did not significantly affect the titration 
of total plasmin. 
FIG. 4.  The effect of crystalline soya bean trypsin inhibitor on the titration of total plasmin 
by the method described.  Ordinates and abscissae as in Fig. 3.  A quantity of inhibitor which 
caused complete inhibition of trypsin did not affect the titration of total plasmin. 
of normal human serum, and 1.0 cc. of streptokinase suitably diluted in buffer-saline  solution. 
This operation was carried out in a cold water bath at about 4°C. and azocoll was added immedi- 
ately in order to allow the smallest possible time for combination of plasmin and inhibitor. 
The tubes were then incubated for digestion as described under Methods.  The whole experi- 
ment was repeated on the following day. 
Fig. 3  gives the mean of the results of these titrations.  It will be seen that, 
under  the  conditions  described,  undiluted  inhibitor  caused  53 per cent inhibi- 3O2  TOTAL  PLASMIN  AND  TRYPSIN  INHIBITOR.  I 
tion of trypsin but it failed to cause any inhibition of plasmin.  The color re- 
leased from azocoll by the two enzymes alone without any inhibitor averaged 
36 units for trypsin and 40 units for plasmin. 
A  similar experiment  was  carried out using crystalline soya bean  trypsin 
inhibitor instead of bovine inhibitor.  In  this experiment a  quantity of in- 
hibitor which was large enough to inhibit the trypsin completely did not cause 
any inhibition of plasmin.  The color units released from azocoll by the two 
enzymes alone without any inhibitor were 63  units for trypsin and 52  units 
for plasmin.  The result of this experiment is shown in Fig. 4. 
These  experiments  add  confirmation to  the  results  already expressed  in 
Fig. 2.  The experiments recorded in Figs. 2, 3, and 4 all seem to show that 
the methods employed for the separate titration of total plasmin and of trypsin 
inhibitor give independent results and that the levels of plasmin determinations 
are not necessarily low because the serum contains a  large amount of trypsin 
inhibitor. 
The Effect of Spontaneously Activated Plasmin on the Titration  of Trypsin 
Inhibitor 
When titrating trypsin inhibitor in serum the dilution of 1/25,000 is sufficient 
to insure that autocatalytically activated plasminogen, which appears on stor- 
age of sera in the cold, will not supply sufficient plasmin to interfere with the 
test.  This was demonstrated by an experiment in which twenty-three speci- 
mens of patients' sera,  containing various  quantities of  total plasmin repre- 
sented by color unit readings ranging from 32 to 56, were diluted 1/25,000  and 
tested for their action on 30  nag. of azocoU.  Buffer-saline was used as  the 
reference in this experiment.  The light transmittance without any serum was 
79 per cent; the mean transmittance for all the sera was 78.5 per cent with a 
variation of +2.0 or -- 1.5.  It is therefore evident that the quantity of serum 
used  for  titrations of  trypsin inhibitor is  sufficiently small  to  exclude any 
proteolytic action of plasmin. 
The Effect of the Inhibitor  in Streptokinase on the Estimation  of Total Plasmin 
Christensen and MacLeod (1945) have shown that concentrated solutions of 
streptokinase contain proteinase inhibitor.  It is therefore necessary to titrate 
the streptokinase used for activation of plasminogen to determine the optimal 
concentration which  will  cause  maximal activation of plasminogen without 
introducing enzyme inhibitors which are known to be present in concentrated 
preparations of streptokinase. 
For this purpose serial twofold dilutions of a solution containing 25 mg. of partially purified 
streptokinase (S.K.A.I.) in  10.0 cc. of distilled water were pipetted into a  series of digestion 
tubes in volumes of 0.4 cc.  A  volume of 0.4 cc. of normal human serum was added to each ~DGAR w.  TODD  303 
tube; and the total volume was then made up to 4.0 cc. with buffer-saline solution at pH 7.8. 
Mter the addition of 30 rag. of azocoll and incubation for 30 minutes as previously described, 
the tests  were read in the usual way.  A similar experiment was set up in which patient's 
serum with an anfistreptokinase  titre of 1/2560 was used instead  of normal human serum. 
The results of these experiments are given in Table II. 
It will be seen from Table II, that, with normal human serum 0.25 and 0.125 
rag. of this particular preparation of streptokinase produced maximal plasmin 
activity.  Larger or smaller quantities were less effective.  A  quantity of 0.25 
TABLE II 
Determination of Optimal Quantity of Streptokinase for  Use in  Titration  of Total Plasmin 
Streptokinase 
mg. 
1.0 
0.5 
0.25 
0.125 
0.063 
0.031 
0.016 
0.008 
0.004 
Normal human serum 
Color units 
39 
43 
49 
49 
47 
42 
34 
31 
30 
Patient's  serum A.S.K.  tltre 1/2500 
41 
43 
42 
34 
29 
•  .  .  =  not done. 
A.S.K.  =  antistreptokinase. 
mg.  of  this  streptokinase,  therefore,  allowed  the  largest  possible  margin  of 
excess streptokinase  for the  titration  of total  plasmin  in sera  with  low anti- 
streptokinase  titres.  With the patient's serum, however, maximal proteolytic 
activity was observed with a  minimal  quantity  of 0.25  rag.  of streptokinase. 
Smaller quantities of streptokinase gave rapidly diminishing proteolytic action 
which  was presumably  due  to  the  large  amount  of antistreptokinase  in  the 
patient's serum.  Since 1/2560 was, with a  single exception,  the highest anti- 
streptokinase  titre  encountered  among the  sera  used  in  this  investigation,  a 
quantity  of 0.25  mg.  of streptokinase  was  selected  for  use  in  total  plasmin 
titrations. 
The Effect  of Antistreptokinase  on the  Titration of Total Plasmin 
The following experiment was carried out to determine whether or not 0.25 
rag. of the partially purified streptokinase  (S.K.A.I.) was sufficient to activate 
the plasminogen of patients'  sera  containing varying amounts of antistrepto- 
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Sera from twenty-two scarlet fever patients with antistreptokinase titres ranging from 0 to 
1/5120 were titrated for total plasmin in the usual way.  In addition, each of these sera was 
titrated for total plasmin when activated by half the usual quantity of streptokinase.  The 
result of this experiment is given in Table III. 
TABLE III 
The Effect of Antlstreptokinase on the Titration  of Total Plasmin  Using 22 Ser¢ from Scarlet 
Fever Patients with Varying Quantities of Antistreptokinase in Their Blood 
Antistreptokinase 
titres of sers 
(reciprocals  of 
serum  dilutions) 
0 
0 
20 
20 
40 
40 
80 
80 
160 
Proteolytic activity with 
0.25 rag. of streptoklnase 
(color units) 
Proteolytlc  activity  with 
0.125 rag. of streptoklnase 
(color  units) 
160 
320 
320 
640 
640 
1280 
1280 
1280 
2560 
2560 
2560 
2560 
5120 
46 
53 
58.5 
40 
38 
52 
52 
56 
53 
46.5 
34 
39 
33 
39.5 
46 
54.5 
61 
47 
40.5 
47 
59.5 
62 
54 
46 
3O 
44 
37 
40 
43.5 
31.5 
41.5 
35 
34 
43.5 
43.5 
33 
42 
29.5 
36 
31 
38 
39 
40.5 
29 
Increase  or  decrease 
of color  units  withlmlf 
the usual quantity of 
streptoklnase 
0 
+1.5 
+2.5 
+7.0 
+2.5 
-5.0 
+7.5 
+6.0 
+1.0 
-0.5 
-4.0 
+5.0 
+4.0 
+0.5 
--1.5 
-2.0 
--5.5 
-4.0 
+4.0 
-4.5 
--3.0 
-4.0 
It will be seen from Table III that,  with patients' sera which had A.S.K. 
titres ranging from 0  to 1/640,  the usual quantity of 0.25 rag. of streptokinase 
was on the average slightly less efficient as an activator of plasminogen than 
half the usual quantity.  Thus with A.S.K. titres of 1/640, or less, the average 
increase of proteolytic activity with hal/the  usual quantity of streptokinase 
was represented by +2.0 color units.  This was probably due to a slight excess 
of inhibitor in the usual quantity of streptokinase.  On the other hand,  with 
patients' sera which had A.S.K. titres higher than  1/640  the average loss of 
proteolytic activity with half  the usual quantity of streptokinase was repre- 
sented by -- 2.6 color units.  This was probably due to the presence of sufficient 
antistreptokinase to cause partial neutralization of half the usual quantity of EDGAR W.  TODD  305 
activating streptokinase.  It was therefore considered advisable to adopt 0.25 
rag.  of streptokinase as the standard  quantity for activation of plasminogen 
in all titrations. 
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FIG. 5.  Trypsin inhibitor in samples of serum taken at weekly  intervals from a patient with 
scarlet fever.  The sera, which were stored in the cold, were first titrated for trypsin inhibitor 
after 15 months and again after 22 months.  Ordinates  give percentage inhibition of trypsin. 
Abscissae give times when the patient was bled.  The vertical columns give trypsin inhibitor 
levels after 15 and 22 months' storage. 
The Lability of Trypsin Inhibitor in Serum 
It is well known that trypsin inhibitor gradually disappears from samples of 
sterile serum which are stored in the cold.  With animal sera this appears to be 
a relatively rapid process so that samples of serum which were originally capable 
of causing 80 per cent inhibition of trypsin may lose all their inhibitory power 
within a few months.  On the other hand, the trypsin inhibitor of human serum 
appears to lose its inhibitory power much more slowly.  Titrations of trypsin 
inhibitor in human sera, which will be described in a subsequent paper, showed 
that inhibitory action was still demonstrable after storage in the cold for periods 
ranging from 2 to 8 years.  An example may be given of a patient who was bled 
in  June,  1946.  The  trypsin  inhibitor  in  this  serum  was  first  titrated  after 
storage in  the  cold for  15  months  when  it  caused  78  per cent  inhibition  of 
trypsin; after 22 months it caused 53 per cent inhibition and after 24 months, 306  TOTAL  PLASMIIN  AND  TRYPSIN  INHIBITOR.  I 
46 per cent inhibition.  A similar gradual loss of trypsin inhibitor in serum is 
illustrated  in  Fig.  5.  In  this  case  five samples  of  serum  taken,  at  weekly 
intervals, from the same patient were titrated for trypsin inhibitor 15 months 
after bleeding and again 22 months after bleeding. 
It will  be  seen  from Fig.  5  that  two  approximately parallel  curves  were 
obtained with a loss of from 27 to 34 per cent of inhibitory power in all the sera 
during the 7 month interval.  This is an unusually uniform fall in the inhibitory 
power of a series of samples of serum after storage in the cold.  In experiments 
of this kind irregular changes in the inhibitory power of sera frequently occur 
so that two curves which are not of the same shape are obtained.  This sug- 
gests that the trypsin inhibitor in fresh human serum may consist of different 
substances which are not equally stable when stored in the cold. 
TABLE IV 
The Stability of Total Plasmin in Sera Taken at Intervals from the Same Patient and Stored in 
the Cold 
Total plasmin activity  expressed  as color  units 
Stored 13  mos.  Stored 23  mos. 
45 
64 
36 
45 
42 
42 
50 
64 
42 
44 
42 
40 
The Stability of Plasminogen in Serum 
An attempt was made to determine whether a  gradual loss of total plasmin 
occurs in human sera which are stored in the cold for long periods.  A series 
of bleedings  taken at  intervals from a  single patient  were  titrated  for total 
plasmin after storage in the cold for 13 months.  This titration was repeated 
10 months later.  The results of this experiment are given in Table IV. 
It will be seen from Table IV that  the largest variation between  the two 
titrations was an apparent  increase of 6  color units  in one of the sera after 
storage  in  the  cold  for an  additional  period  of  10  months.  This  variation 
represents a  5 per cent variation in light  transmittance  and it is within  the 
limits of experimental error.  It is therefore evident that plasminogen in serum 
is relatively stable when compared with trypsin inhibitor. 
DISCUSSION 
The object of these experiments was to devise methods by which  separate 
determinations could be made of the total plasmin in human serum and of the EDGAR  W.  TODD  307 
quantity of trypsin inhibitor in the same sample of serum.  By this means it 
was  hoped to  be able  to plot  curves representing respectively the  potential 
proteolytic activity of the serum and the inhibitory action of the same serum on 
proteolysis.  When these curves are constructed in such a way as to follow the 
course of a patient's illness by means of weekly samples of serum, the relation 
of the two curves will indicate the periods of disease when potential proteolysis 
is at its maximum or at its minimum.  Thus when the total plasmin level is 
high and the inhibitor level is low a high potential proteolytic activity may be 
assumed.  Conversely a low total plasmin level coinciding with a high inhibitor 
level  would  indicate  minimal  potential  proteolytic activity.  Evidence  has 
been presented in this paper that, by the methods described, an approximation 
to the separate titration of enzyme and inhibitor in the same serum can be 
made.  The age of the serum is an important factor because plasminogen is 
relatively stable in comparison with trypsin inhibitor. 
The titration of total plasmin in serum is carried out by activating the plas- 
minogen  with  excess of  streptokinase.  This  involves  consideration  of  the 
plasmin  inhibitor  in  streptokinase.  Unconcentrated  streptococcal  filtrates 
cannot be used for activation because the necessary quantity of streptokinase 
would occupy too large a volume.  It is therefore necessary to use concentrated 
and partially purified streptokinase in a solution containing the largest possible 
quantity of activator which will not cause inhibition of plasmin activity.  It is 
also  necessary to  use  a  quantity  of streptokinase  which  is  large  enough  to 
combine with antistreptokinase in the patient's serum leaving sufficient excess 
of streptokinase for full activation of plasminogen. 
The quantity of trypsin inhibitor in sera is estimated by allowing the inhibitor 
in 0.00016 cc. of serum to combine with 0.00025  mg. of crystalline trypsin and 
titrating the residual active trypsin.  By using this small quantity of serum in 
trypsin inhibitor titrations the proteolytic action of the system is confined to 
residual active trypsin and proteolysis by plasmin is excluded. 
SUMMARY 
Methods  are described for the separate titration  of total plasmin and of 
trypsin inhibitor  in human blood serum.  Azocoll was used as the substrate 
in all experiments. 
When  titrating the total plasmin, interference by trypsin inhibitor was 
minimized by mixing together serum, streptokinase,  and substrate in the cold 
before incubation was commenced. 
When  titrating  the trypsin inhibitor,  interference by plasmin was avoided 
by using small quantities  of serum and of crystalline  trypsin. 
Experimental  results show  that with the methods  employed  neither the 
trypsin inhibitor  in the serum nor the inhibitor  in the streptokinase nor the 308  TOTAL  PLASMIN  AND  TRYPSIN  INHIBITOR.  I 
antistreptokinase in the serum significantly  interfered with the results of titra- 
tions of total plasmin. 
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